Aflac Incorporated reported its financial results for the second quarter and first half of 2026, revealing a total revenue of $4.1 billion for the quarter, a slight decrease from $4.2 billion in the same period of 2025. For the first six months, total revenues increased to $8.5 billion from $7.6 billion year-over-year. The company’s net earnings for the second quarter were $825 million, or $1.63 per diluted share, compared to $599 million, or $1.11 per diluted share, in the prior year. The first half of 2026 saw net earnings rise to $1.8 billion, or $3.61 per diluted share, from $628 million, or $1.16 per diluted share, in 2025. The improved profitability was attributed to a reduction in net investment losses, which were $104 million in the first half of 2026 compared to $1.4 billion in the same period of 2025.
The company experienced notable changes in its operational metrics. Aflac Japan's net earned premiums decreased by 12.7% to $1.5 billion in the second quarter, primarily due to an external reinsurance transaction and limited-pay products reaching premium paid-up status. In contrast, Aflac U.S. reported a 2.3% increase in net earned premiums to $1.5 billion, driven by improved sales and strong persistency. The total benefits and claims for Aflac Japan decreased, reflecting higher reserve remeasurement gains, while Aflac U.S. saw an increase in claims due to higher incurred claims for certain group products.
Strategically, Aflac has continued to focus on its share repurchase program, buying back 17.5 million shares for $2 billion in the first half of 2026, compared to 16.4 million shares for $1.7 billion in the same period of 2025. The company also declared a cash dividend of $0.61 per share for the second quarter of 2026, up from $0.58 in the same quarter of 2025. As of June 30, 2026, Aflac had approximately 22 million individual policies in force in Japan, including about 14 million cancer policies.
In terms of operational developments, Aflac Japan's investment portfolio includes both yen-denominated and U.S. dollar-denominated securities, with a focus on maintaining a diversified portfolio to manage risks associated with currency fluctuations. The company reported total investments of $103 billion as of June 30, 2026, with a significant portion in fixed maturity securities. The company’s total assets decreased slightly from $116.5 billion at the end of 2025 to $115.9 billion by mid-2026, reflecting changes in investment valuations and operational cash flows.
Looking ahead, Aflac remains cautious about market conditions, particularly regarding foreign currency fluctuations and interest rate risks. The company continues to evaluate its investment strategies and operational efficiencies to enhance profitability and shareholder value. The annualized return on average shareholders’ equity for the second quarter of 2026 was reported at 10.9%, indicating a stable performance despite the challenges posed by external market factors.
About AFLAC INC
Aflac Incorporated is a leading provider of supplemental health and life insurance, primarily serving customers in Japan and the U.S. Its key offerings include cancer and medical insurance products designed to alleviate financial stress during health crises. With a focus on innovation and digital sales, Aflac targets a growing market of consumers facing rising out-of-pocket medical costs. The company is enhancing its product portfolio and expanding distribution channels to meet evolving customer needs.
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.
View the complete official filing on the SEC website.
Read on SEC.gov